1 Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54. https://doi.org/10.1007/s11912-011-0203-y
2 Brastianos PK, Curry WT, Oh KS (2013) Clinical discussion and review of the management of brain metastases. J Natl Compr Canc Netw 11:1153–64. https://doi.org/10.6004/jnccn.2013.0133
3 Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M et al (2018) Profiles of brain metastases: Prioritization of therapeutic targets. Int J Cancer 143: 3019–3026. https://doi.org/10.1002/ijc.31624
4 Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7: 392–401. https://doi.org/10.1016/S1470-2045(06)70665-9
5 Kuroiwa T, Kajimoto Y, Ohta T (1998) Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report. Surg Neurol 50: 41–49. https://doi.org/10.1016/s0090-3019(98)00055-x
6 Kuroiwa T, Kajimoto Y, Ohta T (1999) Comparison between operative findings on malignant glioma by a fluorescein surgical microscopy and histological findings. Neurol Res 21:130–134. https://doi.org/10.1080/01616412.1999.11740909
7 Gates M, Alsaidi M, Kalkanis S (2012) Surgical treatment of solitary brain metastases. Prog Neurol Surg 25:74–81. https://doi.org/10.1159/000331178
8 Lee CH, Kim DG, Kim JW, Han JH, Kim YH et al (2013) The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study. Acta Neurochir 155:389–397. https://doi.org/10.1007/s00701-013-1619-y
9 Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500. https://doi.org/10.1056/NEJM199002223220802
10 Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid D5-ALA]- induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 54:223–228. https://doi.org/10.1007/s00701-011-1200-5
11 Marbacher S, Klinger E, Schwyzer L, Fischer I, Nevzati E, Diepers M, Roelcke U, Fathi AR, Coluccia D, Fandino J (2014) Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 36:E10. https://doi.org/10.3171/2013.12.FOCUS13464
12 R. Sjöback, J. Nygren, M. Kubista (1995) Absorption and fluorescence properties of fluorescein. Spectrochem. Acta A Mol Biomol Spectrosc. 51: L7–L21. https://doi.org/10.1016/0584-8539(95)01421-P
13 Moore GE (1947) Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 106:130–131. https://doi.org/10.1126/science.106.2745.130-a
14 Moore GE, Peyton WT, French LA, Walker WW (1948) The clinical use of fluorescein in neurosurgery: the localization of brain tumors. J Neurosurg 5:392–398. https://doi.org/10.3171/jns.1948.5.4.0392
15 Okuda T, Kataoka K, Yabuuchi T, Yugami H, Kato A (2010) Fluorescence-guided surgery of metastatic brain tumors using fluorescein sodium. Journal of clinical neuroscience 17:118-121. https://doi.org/10.1016/j.jocn.2009.06.033
16 Okuda T, Kataoka K, Taneda M (2007) Metastatic brain tumor surgery using fluorescein sodium: technical note. Minim Invasive Neurosurg 50:382–4. https://doi.org/10.1055/s-2007-993200
17 Höhne J, Hohenberger C, Proescholdt M, Riemenschneider MJ, Wendl C, Brawanski A, Schebesch KM (2017) Fluorescein sodium- guided resection of cerebral metastases-an update. Acta Neurochir 159:363–367. https://doi.org/10.1007/s00701-016-3054-3
18 Schebesch KM, Hoehne J, Hohenberger C, Proescholdt M, Riemenschneider MJ, Wendl C, Brawanski A (2015) Fluorescein sodium- guided resection of cerebral metastases-experience with the first 30 patients. Acta Neurochir 157:899–904. https://doi.org/10.1007/s00701-015-2395-7
19 Schebesch KM , Proescholdt M, Hohne J, Hohenberger C, Hansen E, Riemenschneider MJ, Ullrich W, Doenitz C et al (2013) Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery--a feasibility study. Acta Neurochir (Wien) 155:693-9. https://doi.org/10.1007/s00701-013-1643-y
20 Xiao SY, Zhang J, Zhu ZQ, Li YP, Zhong WY, Chen JB, Pan ZY, Xia HC (2018) Application of fluorescein sodium in breast cancer brain-metastasis surgery. Cancer management and research 10: 4325-4331. https://doi.org/10.2147/CMAR.S176504
21 Hamancioglu MK, Akçakaya MO, Goker B, Kasimcan MO, Kiris T (2016) The use of the YELLOW 560 nm surgical microscope filter for sodium fluorescein-guided resection of brain tumors: Our preliminary results in a series of 28 patients. Clinical Neurology and Neurosurgery 143: 39-45. https://doi.org/10.1016/j.clineuro.2016.02.006
22 Gollapudi PR, Mohammed I, Pittala SR, Kotha AR, Reddycherla NR, Ginjupally DR (2018) A simple improvisation to enhance the utility of Fluorescein sodium in the resection of intracranial lesions at routine neurosurgical centres. World Neurosurgery 112: 14-17. https://doi.org/10.1016/j.wneu.2018.01.039
23 Falco J, Cavallo C, Vetrano I, De Laurentis C, Siozos L, Schiariti M, Broggi M, Ferroli P, Acerbi F (2019) Fluorescein application in cranial and spinal tumors enhancing at preoperative MRI and operated with a dedicated filter on the surgical microscope: preliminary results in 279 patients enrolled in the FLUOCERTUM prospective study. Frontiers in surgery 6:49. https://doi.org/10.3389/fsurg.2019.00049.eCollection
24 Kofoed MS, Pedersen CB, Schulz MK, Kristensen BW, Hansen RW, Markovic L, Halle B, Poulsen FR (2021) Fluorescein-guided resection of cerebral metastases is associated with greater tumor resection. Acta Neurochir Epub ahead of print. https://doi.org/10.1007/s00701-021-04796-1
25 Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLos Medicine 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
26 Lee CH, Kim DG, Kim JW, Han JH, Kim YH, Park CK, Kim CY, Paek SH, Jung HW (2013) The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study. Acta Neurochir (Wien) 155:389–397. https://doi.org/10.1007/s00701-013-1619-y
27 Kamp MA, Dibue M, Niemann L, Reichelt DC, Felsberg J, Steiger HJ, Szelenyi A, Rapp M, Sabel M (2012) Proof of principle: supramarginal resection of cerebral metastases in eloquent brain areas. Acta Neurochir (Wien) 154:1981–1986. https://doi.org/10.1007/s00701-012-1463-5
28 Acerbi F, Broggi M, Eoli M, Anghileri E, Cavallo C, Boffano C, Cordella R, Cuppini L, Pollo B, Schiariti M, Visintini S, Orsi C, La Corte E, Broggi G, Ferroli P (2014) Is fluorescein-guided technique able to help in resection of high-grade gliomas? Neurosurg Focus 36:E5. http://doi.org/10.3171.2013.11.FOCUS13487